Blood groups and malaria: Fresh insights into pathogenesis and identification of targets for intervention

Current Opinion in Hematology

Volumn 16, Issue 6, 2009, Pages 480-487

  Rowe, J Alexandra ^a   Opi, D Herbert ^a,b   Williams, Thomas N ^b,c,d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

ABO; Duffy; Knops; Plasmodium; Virulence

Indexed keywords

ANTIMALARIAL AGENT; BLOOD GROUP ANTIGEN; MALARIA VACCINE; CELL SURFACE RECEPTOR; DUFFY ANTIGEN BINDING PROTEIN, PLASMODIUM; PARASITE ANTIGEN; PROTOZOAL PROTEIN;

BLOOD GROUP; BLOOD GROUP ABO SYSTEM; BLOOD GROUP DUFFY SYSTEM; CLINICAL TRIAL; HUMAN; MALARIA; MALARIA FALCIPARUM; MULTICENTER STUDY; NONHUMAN; PATHOGENESIS; PLASMODIUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ROSETTE FORMATION; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG EFFECT; IMMUNOLOGY; PATHOPHYSIOLOGY;

ANTIGENS, PROTOZOAN; BLOOD GROUP ANTIGENS; DRUG ADMINISTRATION ROUTES; DRUG DELIVERY SYSTEMS; HUMANS; MALARIA; PLASMODIUM; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE;

EID: 73949121494     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3283313de0     Document Type: Review

References (72)

1. Rowe JA, Ciaessens A, Corrigan RA, et al. Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. Expert Rev Moi Med 2009; 11 :e16.
2. Miller LH, Mason SJ, Dvorak JA, et al. Erythrocyte receptors for {Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 1975; 189:561-563.
3. Miller LH, Mason SJ, Clyde DF, et al. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood- group genotype, FyFy. N Engl J Med 1976; 295:302-304.
4. Tournamllle C, Le Van Kim C, Gane P, et al. Molecular basis and PCR-DNA typing of the Fya/Fyb blood group polymorphism. Hum Genet 1995; 95:407-410.
5. Fukuma N, Aklmltsu N, Hamamoto H, et al. A role of the Duffy antigen for the maintenance of plasma chemokine concentrations. Biochem Biophys Res Commun 2003; 303:137-139.
6. Vergara C, Tsal YJ, Grant AV, et al. Gene encoding Duffy antigen/receptor for chemoklnes Is associated with asthma and IgE in three populations. Am J Respir Crit Care Med 2008; 178:1017-1022.
7. He W, Nell S, Kulkarni H, et al. Duffy antigen receptor for chemoklnes •• mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe 2008; 4:52-62.
8. Reich D, Nalls MA, Kao WH, et al. Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemoklnes gene. PLoS Genet 2009; 5:e1000360.
9. Tournamllle C, Colin Y, Cartron JP, et al. Disruption of a GATA motif In the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995; 10:224-228.
10. Culleton RL, Mita T, Ndounga M, et al. Failure to detect Plasmodium vivax In West and Central Africa by PCR species typing. Malar J 2008; 7:174.
11. Tjltra E, Anstey NM, Suglarto P, et al. Multldrug-reslstant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 2008; 5:e128
12. Genton B, D'Acremont V, Rare L, et al. Plasmodium vivaxamd mixed infections M are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 2008; 5:e127.
13. Zimmerman PA, Woolley I, Maslnde GL, et al. Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea. Proc Natl Acad Sci US A 1999; 96:13973-13977.
14. Kasehagen LJ, Mueller I, Kiniboro B, et al. Reduced Plasmodium vivax erythrocyte Infection in PNG Duffy-negative heterozygotes. PLoS ONE 2007; 2:e336.
15. Beeson JG, Crabb BS. Towards a vaccine against Plasmodium vivax malaria. PLoS Med 2007; 4:e350.
16. Chitnis CE, Sharma A. Targeting the Plasmodium vivax Duffy-binding protein. Trends Parasltol 2008; 24:29-34.
17. Chltnis CE, Miller LH. Identification of the erythrocyte binding domains of Plasmodium vivax Plasmodium knowlesi proteins Involved in erythrocyte invasion. J Exp Med 1994; 180:497-506.
18. Grlmberg BT, Udomsangpetch R, Xainli J, et al. Plasmodium vivax invasion of M human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med 2007; 4:e337.
19. King CL, Michon P, Shakri AR, et al. Naturally acquired Duffy-binding protelnspecific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax Infection. Proc Natl Acad Sci U S A 2008; 105:836b3-8368.
20. Ntumngla FB, McHenry AM, Barnwell JW, et al. Genetic variation among Plasmodium vivax isolates adapted to nonhuman primates and the implication for vaccine development. Am J Trop Med Hyg 2009; 80:218-227.
21. Gosi P, Khusmlth S, Khalambaheti T, et al. Polymorphism patterns In Duffybinding protein among Thai Plasmodium vivax isolates. Malar J 2008; 7: 112.
22. Ryan JR, Stoute JA, Amon J, et al. Evidence for transmission of Plasmodium vivax among a Duffy antigen negative population in Western Kenya. Am J Trop Med Hyg 2006; 75:575-581.
23. Cavasini CE, de Mattos LC, Couto AA, et al. Duffy blood group gene polymorphisms among malaria vivax patients in four areas of the Brazilian Amazon region. Malar J 2007; 6:167.
24. Cavasini CE, Mattos LC, Couto AA, et al. Plasmodium vivax infection among Duffy antigen-negative Individuals from the Brazilian Amazon region: an exception? Trans R Soo Trop Med Hyg 2007; 101:1042-1044.
25. Uneke CJ. Plasmodium falciparum malaria and ABO blood group: is there any relationship? Parasltol Res 2007; 100:759-765.
26. Cserti CM, Dzik WH. The ABO blood group system and Plasmodium falciparum malaria. Blood 2007; 110:2250-2258.
27. Fischer PR, Boone P. Short report: severe malaria associated with blood group. Am J Trop Med Hyg 1998; 58:122-123. (Pubitemid 28071421)
28. Lell B, May J, Schmidt-Ott RJ, et al. The role of red blood cell polymorphisms in resistance and susceptibility to malaria. Clin Infect Dis 1999; 28:794-799.
29. Pathirana SL, Alles HK, Bandara S, et al. ABO-blood-group types and protection against severe, Plasmodium falciparum malaria. Ann Trop Med Parasitai 2005; 99:119-124.
30. Rowe JA, Handel IG, Thera MA, et al. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proo Natl Acad Sci U S A 2007; 104:17471-17476.
31. Fry AE, Griffiths MJ, Auburn S, et al. Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Hum Moi Genet 2008; 17:567-576.
32. Kaul DK, Roth EFJ, Nagel RL, et al. Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances micro-vascular obstruction under flow conditions. Blood 1991 ; 78:812-819.
33. Carlson J, Wahlgren M. Plasmodium falciparum erythrocyte rosetting is medi-ated by promiscuous lectin-like Interactions. J Exp Med 1992; 176:1311-1317.
34. Udomsangpetch R, Todd J, Carlson J, et al. The effects of hemoglobin genotype and ABO blood group on the formation of rosettes by Plasmodium falciparum-infected red blood cells. Am J Trop Med Hyg 1993; 48:149-153.
35. Rowe A, Obelro J, Newbold Cl, et al. Plasmodium falciparum rosetting Is associated with malaria severity in Kenya. Infect Immun 1995; 63:2323-2326.
36. Barragan A, Kremsner PG, Wahlgren M, et al. Blood group A antigen is a coreceptor In Plasmodium falciparum rosetting. Infect Immun 2000; 68:2971- 2975.
37. Chen Q, Heddlnl A, Barragan A, et al. The semlconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple Independent host receptors. J Exp Med 2000; 192:1-10.
38. Jallow M, Teo YY, Small KS, et al. Genome-wide and fine-resolution associait tion analysis of malaria in West Africa. Nat Genet 2009; 41:657-665.
39. Vogt AM, Pettersson F, Moll K, et al. Release of sequestered malaria parasites upon Injection of a glycosamlnoglycan. PLoS Pathog 2006; 2:e100.
40. Kyrlacou HM, Steen KE, Raza A, et al. In vitro Inhibition of Plasmodium falciparum rosette formation by Curdlan sulfate. Antimicrob Agents Che-mother 2007; 51:1321-1326.
41. Chen Q, Pettersson F, Vogt AM, et al. Immunization with PfEMP1 -DBL1 alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium faciparum-infected erythrocytes. Vaccine 2004; 22:2701-2712.
42. Swerdlow DL, Mlntz ED, Rodriguez M, et al. Severe life-threatening cholera associated with blood group O In Peru: implications for the Latin American epidemic. J Infect Dis 1994; 170:468-472.
43. Black RE, Levine MM, Clements ML, et al. Association between O blood group and occurrence and severity of diarrhoea due to Escherichia coli. Trans R Soc Trop Med Hyg 1987; 81:120-123.
44. Daniels G, Flegel WA, Fletcher A, et al. International Society of Blood Transfusion Committee on Terminology for Red Cell Surface Antigens: Cape Town report. Vox Sang 2007; 92:250-253.
45. Daniels GL, Fletcher A, Garratty G, et al. Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens. Vox Sang 2004; 87:304-316.
46. Moulds JM, Nickells MW, Moulds JJ, et al. The C3b/C4b receptor is recognised by the Knops, McCoy, Swain-Langley and York blood group antisera. J Exp Med 1991; 173:1159-1163.
47. Moulds JM Zimmerman PA, Doumbo OK, et al. Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 2001; 97:2879-2885.
48. Tamasauskas D, Powell V, Schawalder A, et al. Localization of Knops system antigens In the long homologous repeats of complement receptor 1. Transfu-sion 2001; 41:1397-1404.
49. Khera R, Das N. Complement receptor 1 : disease associations and therapeutic implications. Moi Immunol 2008; 46:761-772.
50. Rowe JA, Moulds JM, Newbold Cl, et al. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 1997; 388:292-295.
51. Rowe JA, Rogerson SJ, Raza A, et al. Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the Importance of CR1 in rosetting In field isolates. J Immunol 2000; 165:6341-6346.
52. Molthan L The status of the McCoy/Knops antigens. Med Lab Sci 1983; 40:59-63.
53. Wilson JG, Murphy EE, Wong WW, et al Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med 1986; 164:50-59.
54. Moulds JM, Moulds JJ, Brown M, et al. Antiglobulin testing for CR1-related (Knops/McCoy/Swaln-Langley/York) blood group antigens: negative and weak reactions are caused by variable expression of CR1. Vox Sang 1992;62:230-235.
55. Xlang L, Rundles JR, Hamilton DR, et al. Quantitative alleles of CR1 : coding sequence analysis and comparison of haplotypes In two ethnic groups. J Immunol 1999; 163:4939-4945.
56. Cockburn IA, Mackinnon MJ, O'Donnell A, et al. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc Natl Aci Sci U S A 2004; 101:272-277.
57. Nagayasu E, lto M, Akaki M, et al. CR1 density polymorphism on erythrocytes of falciparum malaria patients In Thailand. Am J Trop Med Hyg 2001 ; 64:1-5. (Pubitemid 32550088)
58. Teeranaipong P, Ohashi J, Patarapotikul J, et al. A functional single-nucleotide polymorphism In the CR1 promoter region contributes to protection against cerebral malaria. J Infect Dis 2008; 198:1830-1891.
59. Thomas BN, Donvito B, Cockburn I, et al. A complement receptor-1 polymorphism with high frequency in malaria endemic regions of Asia but not Africa. Genes Immun 2005; 6:31-36. (Pubitemid 40260131)
60. Slnha S, Jha GN, Anand P, et al. CR1 levels and gene polymorphisms exhibit M differential association with falciparum malaria In regions of varying disease endemlolty. Hum Immunol 2009; 70:244-250.
61. Owuor BO, Odhlambo CO, Otleno WO, et al. Reduced immune complex • binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia. Moi Med 2008; 14:89-97.
62. Mibei EK, Otieno WO, Orago AS, et al. Distinct pattern of class and subclass antibodies in immune complexes of children with cerebral malaria and severe malarial anaemia. Parasite Immunol 2008; 30:334-341.
63. Bellamy R, Kwiatkowski D, Hill AV. Absence of an association between Intercellular adhesion molecule 1, complement receptor 1 and interleukIn 1 receptor antagonist gene polymorphisms and severe malaria in a West African population. Trans R Soc Trop Med Hyg 1998; 92:312-316. (Pubitemid 28286933)
64. Herrera AH, Xiang L, Martin SG, et al. Analysis of complement receptor type 1 (CRD expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol lmmunopathol 1998; 87:176-183.
65. Rowe JA, Raza A, Diallo DA, et al. Erythrocyte CR1 expression level does not correlate with a Hindlll restriction fragment length polymorphism In Africans: implications for studies on malaria susceptibility. Genes Immun 2002; 3:497-500.
66. Zimmerman PA, Fitness J, Moulds JM, et al. CR1 Knops blood group alleles are not associated with severe malaria in the Gambia. Genes Immun 2003; 4:368-373.
67. Thathy V, Moulds JM, Guyah B, et al. Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya. Malar J 2005; 4:54.
68. Barreiro LB, Laval G, Quach H, et al. Natural selection has driven population • differentiation in modern humans. Nat Genet 2008; 40:340-345. (Pubitemid 351311765)
69. Maier AG, Duralsingh MT, Reeder JC, et al. Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat Med 2003; 9:87-92.
70. Mayer DC, Jiang L, Achur RN, et al. The glycophorin C N-linked glycan is a critical component of the ligand for the Plasmodium falciparum erythrocyte receptor BAEBL Proc Natl Acad Sci U S A 2006; 103:2358-2362.
71. Mayer DC, Cofle J, Jiang L, et al. Glycophorin B is the erythrocyte receptor of • Plasmodium falciparum erythrocyte-bindlng ligand, EBL.1. Proc Natl Acad Soi U S A 2009; 106:5348-5352.
72. Miller LH. Impact of malaria on genetic polymorphism and genetic diseases In Africans and African Americans. Proc Natl Acad Sci USA 1994; 91:2415-2419.s